Streetbeat News

Price Targets

CHPT

UBS analyst Robert Jamieson has initiated coverage on ChargePoint Holdings (NYSE:CHPT) with a Buy rating and a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 9:07 am

SOUN

DA Davidson analyst Gil Luria initiates coverage on SoundHound AI (NASDAQ:SOUN) with a Buy rating and announces a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 9:03 am

PGNY

Canaccord Genuity analyst Richard Close has initiated coverage on Progyny (NASDAQ:PGNY) with a Buy rating and a price target of $46.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 9:00 am

CRGY

Stephens & Co. analyst Mike Scialla has initiated coverage on Crescent Energy (NYSE:CRGY) with an Overweight rating and a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 8:54 am

NUVL

Stifel analyst Bradley Canino has initiated coverage on Nuvalent (NASDAQ:NUVL) with a Buy rating and a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 8:52 am

CRSP

Mizuho analyst Salim Syed has initiated coverage on CRISPR Therapeutics (NASDAQ:CRSP) with a Buy rating and a price target of $82.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 8:50 am

ICPT

Canaccord Genuity analyst Edward Nash has downgraded Intercept Pharma (NASDAQ:ICPT) from Buy to Hold and lowered the price target from $20 to $19.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 8:45 am

NTNX

Keybanc analyst Thomas Blakey maintains an Overweight rating on Nutanix (NASDAQ:NTNX) and raises the price target from $45 to $46.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 8:37 am

DHR

Keybanc analyst Paul Knight has maintained an Overweight rating on Danaher (NYSE:DHR) but lowered the price target from $325 to $300.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 8:34 am

PLRX

Needham analyst Joseph Stringer has reiterated a 'Buy' rating on Pliant Therapeutics (NASDAQ:PLRX) and maintained a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 8:30 am